The leader in quality education and networking through//conferences, courses and custom training
Choose your language
Japan
Traditional Chinese
Simplified Chinese
English

Biopharmaceutical Development & Production Week

ºê·Î¼Å(PDF)

À̺¥Æ® ͏°´õ

Biopharmaceutical Development & Production Week

Obtain the Tools & Strategies You Need to Achieve Your Development & Production Goals

Interactive & Customized Learning · Perspectives from Multiple Disciplines · Meet Industry Experts & Future Partners

2012³â 2¿ù 27ÀÏ-3¿ù 2ÀÏ · Hilton San Diego Bayfront Hotel · San Diego, CA

Week Overview

Biopharmaceutical Development & Production Week 2012
(»ý¹°ÀǾàǰ °³¹ß ¹× Á¦Á¶ 2012)
2012³â 2¿ù 27ÀÏ-3¿ù 2ÀÏ | ¹Ì±¹, »÷µð¿¡°í

»ý¹° ÀǾàǰ¿¡ ´ëÇÑ ´Ù¾çÇÑ ÇÁ·Î±×·¥À»
¸¶·ÃÇÏ¿´½À´Ï´Ù!

IBC°¡ ÁÖÃÖÇÏ´Â Biopharmaceutical Development & Production Week´Â 9°³ ÄÁÆÛ·±½º°¡ ¸¶·ÃµÇ¾ú°í, Âü°¡ÀÚ°¡ ¿øÇÏ´Â ³»¿ëÀ» ¼±ÅÃÇÒ ¼ö ÀÖ¾î ÃÖÀûÀÇ Á¤º¸¸¦ ¾òÀ» ¼ö ÀÖ´Â Çà»ç·Î ±¸¼ºµÇ¾ú½À´Ï´Ù.

2012³â 2¿ù 27ÀϺÎÅÍ 3¿ù 2ÀϱîÁö »÷µð¿¡°í¿¡¼­ °³ÃֵǴ À̹ø Çà»ç¿¡ ¸¹Àº °ü½É ºÎŹ µå¸³´Ï´Ù.

1ÁÖÀϰ£ ÁøÇàµÇ´Â º» Çà»ç´Â 9°³ ÄÁÆÛ·±½º·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù.

Antibody Development & Production(Ç×ü °³¹ß°ú Á¦Á¶)
¹ÙÀÌ¿ÀÇÁ·Î¼¼½ÌÀÇ ¹®Á¦Á¡ ±Øº¹À» À§ÇÑ ±â¾÷ Çù·Â°ú ±â¼ú ¹× °úÇÐ Çõ½ÅÀÇ ÅëÇÕ
2012³â 2¿ù 29ÀÏ¡­3¿ù 2ÀÏ
» ÄÁÆÛ·±½º °³¿ä
» °úÇÐÀÚ¹®À§¿øÈ¸
» ¾ÆÁ¨´Ù

Process and Product Validation
(ÇÁ·Î¼¼½º¿Í Á¦Ç°ÀÇ °ËÁõ)

Áö¼ÓÀû °ËÁõÀ» À§ÇÑ ¼ö¸íÁÖ±â¿Í ¸®½ºÅ© ±â¹Ý Á¢±Ù¹ýÀ¸·ÎÀÇ À̵¿
2012³â 2¿ù 27ÀÏ¡­28ÀÏ
» ÄÁÆÛ·±½º °³¿ä
» ¾ÆÁ¨´Ù
Technology Transfer for Biopharmaceuticals
(»ý¹°ÀǾàǰÀÇ ±â¼ú ÀÌÀü)

½Ã¼³ÀÇ Ã³¸® ´É·Â Çâ»ó°ú Á¦Á¶ ½Ã°£ ´ÜÃàÀ» ÅëÇØ ±â¼ú ÀÌÀü¿¡ ÀÇÇÑ Á¦ÈÞ ¼º°ú º¸Àå
February 27-28, 2012
» ÄÁÆÛ·±½º °³¿ä
» ¾ÆÁ¨´Ù
Outsourcing Manufacturing of Biopharmaceuticals
(»ý¹°ÀǾàǰ Á¦Á¶¾÷¹« ¾Æ¿ô¼Ò½Ì)

ÀǾàǰ Á¦Á¶À§Å¹±â°ü(CMO)°úÀÇ Á¦ÈÞ¿Í °øµ¿ °³¹ßÀÇ ¼º°øÀ» ÅëÇÑ ¸®½ºÅ© Àý°¨ ¹× »ý»ê¼º Çâ»ó ½ÇÇö
2012³â 2¿ù 27ÀÏ¡­28ÀÏ
» ÄÁÆÛ·±½º °³¿ä
» ¾ÆÁ¨´Ù
Recombinant Protein & Complex Biologic Development & Production
(À¯ÀüÀÚ ÀçÁ¶ÇÕ ´Ü¹éÁú ¹× º¹ÀâÇÑ »ý¹°Á¦Á¦ °³¹ß°ú »ý»ê)

»õ·Î¿î ºÐÀÚ °³¹ß¿¡ °ü·ÃµÈ ±â¼ú ¹× °úÇÐ ºÐ¾ß ¹®Á¦Á¡ ±Øº¹À» À§ÇÑ Á¢±Ù¹ý
2012³â 2¿ù 29ÀÏ¡­3¿ù 2ÀÏ
» ÄÁÆÛ·±½º °³¿ä
» °úÇÐÀÚ¹®À§¿øÈ¸
» ¾ÆÁ¨´Ù
Analytical Technologies for Biotherapeutic Development
(»ý¹°ÀǾàǰ °³¹ßÀ» À§ÇÑ ºÐ¼® ±â¼ú)

°³¹ß ÃʱâºÎÅÍ ÃÖÁ¾ ´Ü°è±îÁöÀÇ »õ·Î¿î ºÐ¼® Á¢±Ù¹ý°ú ±â¼ú µµÀÔ¿¡ ÀÇÇÑ ÇÁ·ÎÁ§Æ® ÃßÁø
2012³â 2¿ù 29ÀÏ¡­3¿ù 2ÀÏ
» ÄÁÆÛ·±½º °³¿ä
» °úÇÐÀÚ¹®À§¿øÈ¸
» ¾ÆÁ¨´Ù
Biopharmaceutical Raw Materials throughout the Product Lifecycle
(Á¦Ç° ¼ö¸íÁֱ⿡ °ü·ÃµÈ °¢Á¾ »ý¹°ÀǾàǰ ¿ø·á)

Upstream°ú Downstream °³¹ß °øÁ¤ ¹× ÀÓ»ó½ÃÇè°ú »ó¾÷ »ý»ê ´Ü°è¿¡¼­ ¿ø·áÀÇ º¯µ¿¼ºÀÇ È®ÀÎ, °Ë»ç, °ü¸®¿¡ ÀÇÇÑ ¸®½ºÅ© Àý°¨ Àü·«
2012³â 2¿ù 27ÀÏ¡­28ÀÏ
» ÄÁÆÛ·±½º °³¿ä
» ¾ÆÁ¨´Ù
Viral Safety for Biologicals
(»ý¹°Á¦Á¦ÀÇ ¹ÙÀÌ·¯½º ¾ÈÀü¼º)

Upstream, Downstream, Á¦Á¶ °øÁ¤¿¡¼­ ¹ÙÀÌ·¯½º °ËÃâ, ¿¹¹æ, Ä¡·á¸¦ À§ÇÑ Àü·«, ±â¼ú ¹× ±ÔÁ¦ Àü¸Á
2012³â 2¿ù 27ÀÏ¡­28ÀÏ
» ÄÁÆÛ·±½º °³¿ä
» ¾ÆÁ¨´Ù
Biobetters & Biosimilars: Technologies and Development Strategies
(¹ÙÀÌ¿Àº£ÅÍ¿Í ¹ÙÀÌ¿À½Ã¹Ð·¯£º±â¼ú Àü·«°ú °³¹ß Àü·«)

¹Ì·¡ »ç¾÷¼º°ú ½ÇÁúÀûÀÎ ºñÁö´Ï½º ±âȸ ºÐ¼® ´Ü°è
2012³â 2¿ù 29ÀÏ¡­3¿ù 2ÀÏ
» ÄÁÆÛ·±½º °³¿ä
» °úÇÐÀÚ¹®À§¿øÈ¸
» ¾ÆÁ¨´Ù

Çà»ç ÀåÁ¡

  • »ý¹°ÀǾàǰ ¿¬±¸°³¹ß¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖ´Â ½Ç¿ëÀûÀÎ Àü·«ÀÇ ¹ß°ß
    ¾÷°è Àü¹®°¡·ÎºÎÅÍ ´Ù¾çÇÑ ³»¿ëÀ» ¹è¿ì°í, °¢Á¾ µ¥ÀÌÅ͸¦ ÀÌ¿ëÇÑ »ç·Ê ¿¬±¸¸¦ ÅëÇØ °³¹ß°ú Á¦Á¶¾÷¹«¿¡ Àçºü¸£°Ô ÀÀ¿ëÇÒ ¼ö ÀÖ´Â »õ·Î¿î ¾ÆÀ̵ð¾î¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
  • Àü½Ã ±â¾÷ÀÇ »õ·Î¿î ±â¼ú
    20°³ ÀÌ»óÀÇ Àü½Ã±â¾÷ÀÌ Âü°¡ÇÏ´Â Àü½ÃȸÀå¿¡¼­ ½ÇÁ¦·Î Á¦Ç°À» º¸°í, ¸¸Áö°í, ºñ±³Çϸ鼭 ÃÖÀûÀÇ ±â±â¸¦ ãÀ» ¼ö ÀÖ½À´Ï´Ù.
  • 100¸íÀÌ ³Ñ´Â Àü¹®°¡ÀÇ °­¿¬
    Âü°¡ ½ÅûÇÑ ³¯Â¥¿¡ °³ÃֵǴ ÄÁÆÛ·±½ºÀÇ ¸ðµç ¼¼¼Ç¿¡ Âü°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ´Ù¾çÇÑ »ê¾÷ ºÐ¾ß °ü°èÀÚ¿ÍÀÇ ³×Æ®¿öÅ· ±âȸ
    ³×Æ®¿öÅ·À» ¸ñÀûÀ¸·Î ÇÑ Ä¿ÇÇ Å¸ÀÓ°ú ¼¼¼ÇÀÌ ¿¹Á¤µÇ¾î ÀÖÀ¸¸ç, 9°³ ÄÁÆÛ·±½º¿¡ Âü°¡Çϰí ÀÖ´Â ÇÁ·Î¼¼½º °³¹ß Àü¹®°¡¿Í °¨µ¶±â°ü, Á¦Á¶±â¾÷ÀÇ ÁÖ¿ä Àλç¿Í Á÷Á¢ ¸¸³ª À̾߱⸦ ³ª´­ ¼ö ÀÖ½À´Ï´Ù.
Çѱ¹¾î °ø½Ä»çÀÌÆ® ¿î¿µ : IBC Life Sciences ÆÄÆ®³Ê
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼Ç